OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用是常见，但严重到足以程度是罕见。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺多巴胺激动剂，与第一代多巴胺激动剂不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴胺D2受体有较高结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似的激动剂，与第一代激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明与D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激动剂，与第一代多巴胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动临床应疗性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期性腺激素释放因子治疗相关的是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激动，与第一代多巴胺激动不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激动剂，与第一代多巴胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴的多巴激动剂，与第一代多巴激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴D2受有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激动剂，与第一代多巴胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺激动应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激动，与第一代多巴胺激动不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用是常见，但严重到足以停药程度是罕见。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺多巴胺激动剂，第一代多巴胺激动剂不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其多巴胺D2受体有较高结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受激床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激，与第一代多巴胺激不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受有较高的结合力。